These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 1562683)

  • 1. Candidemia in immunocompromised patients.
    Meunier F; Aoun M; Bitar N
    Clin Infect Dis; 1992 Mar; 14 Suppl 1():S120-5. PubMed ID: 1562683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
    Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J
    Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer.
    Bodey GP; Mardani M; Hanna HA; Boktour M; Abbas J; Girgawy E; Hachem RY; Kontoyiannis DP; Raad II
    Am J Med; 2002 Apr; 112(5):380-5. PubMed ID: 11904112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candida krusei fungemia. An escalating serious infection in immunocompromised patients.
    Abbas J; Bodey GP; Hanna HA; Mardani M; Girgawy E; Abi-Said D; Whimbey E; Hachem R; Raad I
    Arch Intern Med; 2000 Sep; 160(17):2659-64. PubMed ID: 10999981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breakthrough candidemia in patients with cancer differs from de novo candidemia in host factors and Candida species but not intensity.
    Kontoyiannis DP; Reddy BT; Hanna H; Bodey GP; Tarrand J; Raad II
    Infect Control Hosp Epidemiol; 2002 Sep; 23(9):542-5. PubMed ID: 12269454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood stream infections by Candida glabrata and Candida krusei: a single-center experience.
    Choi HK; Jeong SJ; Lee HS; Chin BS; Choi SH; Han SH; Kim MS; Kim CO; Choi JY; Song YG; Kim JM
    Korean J Intern Med; 2009 Sep; 24(3):263-9. PubMed ID: 19721864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candidemia in women with breast carcinoma treated with high-dose chemotherapy and autologous bone marrow transplantation.
    Gottfredsson M; Vredenburgh JJ; Xu J; Schell WA; Perfect JR
    Cancer; 2003 Jul; 98(1):24-30. PubMed ID: 12833451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Candidemia in patients with hematologic malignancies: analysis of 7 years' experience in a single center.
    Vigouroux S; Morin O; Moreau P; Harousseau JL; Milpied N
    Haematologica; 2006 May; 91(5):717-8. PubMed ID: 16670081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nosocomial Candida krusei fungemia in cancer patients: report of 10 cases and review.
    Krcmery V; Spanik S; Kunova A; Trupl J; Grausova S; Krupova I; Mateicka F; Pichnova E; Grey E; Sabo A
    J Chemother; 1999 Apr; 11(2):131-6. PubMed ID: 10326744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiological characteristics of fatal Candida krusei fungemia in immunocompromised febrile neutropenic children.
    Agirbasli H; Otlu B; Bilgen H; Durmaz R; Gedikoglu G
    Infection; 2008 Feb; 36(1):88-91. PubMed ID: 18084719
    [No Abstract]   [Full Text] [Related]  

  • 11. Prior antimicrobial therapy and risk for hospital-acquired Candida glabrata and Candida krusei fungemia: a case-case-control study.
    Lin MY; Carmeli Y; Zumsteg J; Flores EL; Tolentino J; Sreeramoju P; Weber SG
    Antimicrob Agents Chemother; 2005 Nov; 49(11):4555-60. PubMed ID: 16251295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current treatment of candidemia in non-neutropenic patients. Amphotericin B or fluconazole? A retrospective study of 62 consecutive patients].
    Cobo Reinoso P; Aguado García JM; Lumbreras Bermejo C; Pérez Vela JL; Caballero Cubedo R; Sanz Sanz F; Noriega Rodríguez AR
    Rev Clin Esp; 1997 Dec; 197(12):799-803. PubMed ID: 9477669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of high-dose granulocyte transfusions in patients with cancer with candidemia: retrospective case-control analysis of 491 episodes of Candida species bloodstream infections.
    Safdar A; Hanna HA; Boktour M; Kontoyiannis DP; Hachem R; Lichtiger B; Freireich EJ; Raad II
    Cancer; 2004 Dec; 101(12):2859-65. PubMed ID: 15529309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy.
    Hachem R; Hanna H; Kontoyiannis D; Jiang Y; Raad I
    Cancer; 2008 Jun; 112(11):2493-9. PubMed ID: 18412153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution and epidemiology of Candida species causing fungemia at a Saudi Arabian hospital, 1996-2004.
    Al-Tawfiq JA
    Int J Infect Dis; 2007 May; 11(3):239-44. PubMed ID: 16859945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The predictors of outcome in immunocompetent patients with hematogenous candidiasis.
    Safdar A; Bannister TW; Safdar Z
    Int J Infect Dis; 2004 May; 8(3):180-6. PubMed ID: 15109594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk Factors for Candida tropicalis fungemia in patients with cancer.
    Kontoyiannis DP; Vaziri I; Hanna HA; Boktour M; Thornby J; Hachem R; Bodey GP; Raad II
    Clin Infect Dis; 2001 Nov; 33(10):1676-81. PubMed ID: 11568858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
    Horn DL; Neofytos D; Anaissie EJ; Fishman JA; Steinbach WJ; Olyaei AJ; Marr KA; Pfaller MA; Chang CH; Webster KM
    Clin Infect Dis; 2009 Jun; 48(12):1695-703. PubMed ID: 19441981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007): stable incidence but changing epidemiology of a still frequently lethal infection.
    Sipsas NV; Lewis RE; Tarrand J; Hachem R; Rolston KV; Raad II; Kontoyiannis DP
    Cancer; 2009 Oct; 115(20):4745-52. PubMed ID: 19634156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breakthrough fungemia caused by fluconazole-resistant Candida albicans with decreased susceptibility to voriconazole in patients with hematologic malignancies.
    Myoken Y; Kyo T; Sugata T; Murayama SY; Mikami Y
    Haematologica; 2006 Feb; 91(2):287-8. PubMed ID: 16461328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.